Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
In previous studies the authors discovered that miR-214 inhibits osteoblastic bone formation. Here they extend on these findings, using ovariectomized mice and samples from patients with bone fractures, to show that miR-214 is a mediator of osteoclast-osteoblast crosstalk.
Main Authors: | Defang Li, Jin Liu, Baosheng Guo, Chao Liang, Lei Dang, Cheng Lu, Xiaojuan He, Hilda Yeuk-Siu Cheung, Liang Xu, Changwei Lu, Bing He, Biao Liu, Atik Badshah Shaikh, Fangfei Li, Luyao Wang, Zhijun Yang, Doris Wai-Ting Au, Songlin Peng, Zongkang Zhang, Bao-Ting Zhang, Xiaohua Pan, Airong Qian, Peng Shang, Lianbo Xiao, Baohong Jiang, Chris Kong-Chu Wong, Jiake Xu, Zhaoxiang Bian, Zicai Liang, De-an Guo, Hailong Zhu, Weihong Tan, Aiping Lu, Ge Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10872 |
Similar Items
-
Targeted Delivery Systems for Molecular Therapy in Skeletal Disorders
by: Lei Dang, et al.
Published: (2016-03-01) -
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
by: Atik Badshah Shaikh, et al.
Published: (2016-04-01) -
Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems
by: Feng Jiang, et al.
Published: (2015-10-01) -
Molecular Insight into Gut Microbiota and Rheumatoid Arthritis
by: Xiaohao Wu, et al.
Published: (2016-03-01) -
Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritisResearch in context
by: Xiaojuan He, et al.
Published: (2019-03-01)